Optomed
3.985
EUR
-1.12 %
5,461 following
OPTOMED
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.
Read moreMarket cap
78.48M EUR
Turnover
38.9K EUR
P/E (adj.) (25e)
-15.07
EV/EBIT (adj.) (25e)
-16.5
P/B (25e)
4.15
EV/S (25e)
4.36
Dividend yield-% (25e)
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.8
2025
Interim report Q2'25
6.11
2025
Interim report Q3'25
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Optomed Oyj: Decisions of the Organization Meeting of Optomed's Board of Directors
Optomed Oyj: Decisions of the Annual General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Optomed Oyj: Correction to the pdf-version of Optomed's Annual Report
Redeye: Optomed Q1 - A solid start to the year
Optomed Oyj: Optomed Plc: Interim Report, January - March 2025
Case: Potential impacts of U.S. import tariffs on Helsinki Stock Exchange companies
Optomed Oyj: NOTICE OF THE ANNUAL GENERAL MEETING OF OPTOMED PLC
Optomed Oyj: Optomed Annual Report 2024 published
Redeye: Optomed Q4 - Quarter in line with expectations
Optomed Oyj: Optomed Plc: Financial Statements Bulletin, January - December 2024
Optomed Oyj: Proposal of Optomed's Nomination Board
